1. Home
  2. KITT vs ARTL Comparison

KITT vs ARTL Comparison

Compare KITT & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

N/A

Current Price

$1.60

Market Cap

2.4M

Sector

Industrials

ML Signal

N/A

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$4.00

Market Cap

2.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KITT
ARTL
Founded
2014
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.5M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
KITT
ARTL
Price
$1.60
$4.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
712.2K
★ 1.3M
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.55
N/A
EPS
N/A
★ N/A
Revenue
★ $11,434,959.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 33.10
N/A
52 Week Low
$0.39
$0.52
52 Week High
$3.65
$19.91

Technical Indicators

Market Signals
Indicator
KITT
ARTL
Relative Strength Index (RSI) 65.78 49.69
Support Level $0.64 $3.20
Resistance Level $2.08 $6.81
Average True Range (ATR) 0.17 1.30
MACD 0.15 -0.25
Stochastic Oscillator 46.71 4.89

Price Performance

Historical Comparison
KITT
ARTL

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: